{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:43:37Z","timestamp":1793357017160,"version":"4.5.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5,7]]},"DOI":"10.1093\/eurheartj\/eht507","type":"journal-article","created":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T02:01:13Z","timestamp":1387332073000},"page":"1205-1214","source":"Crossref","is-referenced-by-count":101,"title":["Antihypertensive treatment and risk of atrial fibrillation: a nationwide study"],"prefix":"10.1093","volume":"35","author":[{"given":"Sarah C.W.","family":"Marott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sune F.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Benn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge G.","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,12,17]]},"reference":[{"key":"key\n\t\t\t\t20170516122319_EHT507C1","doi-asserted-by":"crossref","first-page":"2N","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates","volume":"82","author":"Kannel","year":"1998","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170516122319_EHT507C2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1067\/mhj.2002.122875","article-title":"Baseline characteristics of patients with atrial fibrillation: the AFFIRM Study","volume":"143","year":"2002","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170516122319_EHT507C3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/jhh.2011.105","article-title":"Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications","volume":"26","author":"Lau","year":"2011","journal-title":"J Hum Hypertens"},{"key":"key\n\t\t\t\t20170516122319_EHT507C4","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2003.07.014","article-title":"Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease","volume":"42","author":"Boldt","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170516122319_EHT507C5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/eurheartj\/ehi668","article-title":"Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence","volume":"27","author":"Ehrlich","year":"2006","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170516122319_EHT507C6","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0735-1097(03)00464-9","article-title":"Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation","volume":"41","author":"Kumagai","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170516122319_EHT507C7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","article-title":"Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial","volume":"353","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170516122319_EHT507C8","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(99)10327-1","article-title":"Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study","volume":"354","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170516122319_EHT507C9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ahj.2007.04.062","article-title":"Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study","volume":"154","author":"Salehian","year":"2007","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170516122319_EHT507C10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/HJH.0b013e3282f35c67","article-title":"Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial","volume":"26","author":"Schmieder","year":"2008","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20170516122319_EHT507C11","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention for End Point Reduction in Hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170516122319_EHT507C12","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial","volume":"372","author":"Yusuf","year":"2008","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170516122319_EHT507C13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCEP.111.965178","article-title":"Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial","volume":"5","author":"Goette","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"key\n\t\t\t\t20170516122319_EHT507C14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-152-2-201001190-00005","article-title":"Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study","volume":"152","author":"Schaer","year":"2010","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170516122319_EHT507C15","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1503\/cmaj.110167","article-title":"Type of second primary cancer by type of first cancer: a Danish nationwide study","volume":"184","author":"Nielsen","year":"2012","journal-title":"Can Med Ass J"},{"key":"key\n\t\t\t\t20170516122319_EHT507C16","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1182\/blood-2011-02-337170","article-title":"Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia: a nationwide study","volume":"118","author":"Nielsen","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170516122319_EHT507C17","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","article-title":"Statin use and reduced cancer-related mortality","volume":"367","author":"Nielsen","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170516122319_EHT507C18","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.eururo.2011.06.016","article-title":"Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men","volume":"60","author":"Orsted","year":"2011","journal-title":"Eur Urol"},{"key":"key\n\t\t\t\t20170516122319_EHT507C19","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1164\/rccm.200912-1951OC","article-title":"Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study","volume":"181","author":"Sode","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170516122319_EHT507C20","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.jacc.2010.09.013","article-title":"2011 ACCF\/AHA\/HRS focused updates incorporated into the ACC\/AHA\/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society","volume":"57","author":"Fuster","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170516122319_EHT507C21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/bcp.12050","article-title":"AT1 mutations and risk of atrial fibrillation based on genotypes from 71,000 individuals from the general population","volume":"76","author":"Marott","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170516122319_EHT507C22","first-page":"541","article-title":"Experience from a multicentre stroke register: a preliminary report","volume":"54","author":"Hatano","year":"1976","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20170516122319_EHT507C23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4330\/wjc.v4.i6.195","article-title":"Risk stratification of patients with atrial fibrillation: biomarkers and other future perspectives","volume":"4","author":"Providencia","year":"2012","journal-title":"World J Cardiol"},{"key":"key\n\t\t\t\t20170516122319_EHT507C24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s11883-011-0187-y","article-title":"Impact of hypertension on stroke","volume":"13","author":"Dubow","year":"2011","journal-title":"Curr Atheroscler Rep"},{"key":"key\n\t\t\t\t20170516122319_EHT507C25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/HJH.0b013e32834f03bf","article-title":"Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group \u2018Hypertension Arrhythmias and Thrombosis\u2019 of the European Society of Hypertension","volume":"30","author":"Manolis","year":"2012","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20170516122319_EHT507C26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ahj.2005.06.036","article-title":"Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"152","author":"Ducharme","year":"2006","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170516122319_EHT507C27","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ahj.2004.09.033","article-title":"Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)","volume":"149","author":"Maggioni","year":"2005","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170516122319_EHT507C28","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1161\/01.CIR.0000072793.81076.D4","article-title":"Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials","volume":"107","author":"Vermes","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170516122319_EHT507C29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.hrthm.2004.08.008","article-title":"Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM","volume":"1","author":"Murray","year":"2004","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t20170516122319_EHT507C30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0828-282X(08)70670-6","article-title":"Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF)","volume":"24","author":"Palardy","year":"2008","journal-title":"Can J Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/35\/18\/1205\/17154019\/eht507.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T01:28:52Z","timestamp":1503451732000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/eht507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,17]]},"references-count":30,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2013,12,17]]},"published-print":{"date-parts":[[2014,5,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/eht507","relation":{},"ISSN":["1522-9645","0195-668X"],"issn-type":[{"value":"1522-9645","type":"electronic"},{"value":"0195-668X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12,17]]}}}